Anti-CGRP mAbs for post-IIH headache
Key messages
- Anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP mAbs) have the potential to be an effective treatment for headache following idiopathic intracranial hypertension (IIH).
- The final results from this study could inform a treatment protocol for patients with post-IIH headache.